X0306 4 2012-11-30 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532218 Patel Sanj K 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 true true false false President & CEO Common Stock 286 I Held by Abbey Road Investment Group Common Stock 2012-11-30 4 M false 5000 0.95 A 6031 D Common Stock 2012-11-30 4 S false 5000 48.8652 D 1031 D Common Stock 2012-12-03 4 M false 30000 0.95 A 31031 D Common Stock 2012-12-03 4 S false 30000 49.4164 D 1031 D Stock Option (Right to Buy) 0.95 2012-11-30 4 M false 5000 0 D 2019-07-01 Common Stock 5000 230304 D Stock Option (Right to Buy) 0.95 2012-12-03 4 M false 30000 0 D 2019-07-01 Common Stock 30000 200304 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 8, 2011. The stock option granted the reporting person an option to purchase 396,070 Shares. 25% of such Shares vested and became exercisable on 07/01/2010, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. /s/ Sanj K. Patel 2012-12-04